Folotyn
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
the peripheral t-cell lymphomas (ptCLs) are a diverse group of mature t-cell neoplasms that typically display aggressive clinical…
T-cell lymphoma accounts for 10% to 15% of all cases of non-Hodgkin lymphoma in the United States (approximately 5000 to 6000…
Abstract 4745 Mucositis is a frequent complication experienced by patients receiving weekly Pralatrexate, an antifolate agent…
New molecular entity: Pralatrexate injection (Folotyn) was approved on September 24, 2009, for the treatment of patients with…
8054 Background: Pralatrexate (FOLOTYN) is a targeted antifolate designed for preferential uptake and accumulation in tumor cells…